Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Goodwill (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Goodwill for 10 consecutive years, with $1.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Goodwill changed 0.0% to $1.9 million in Q4 2025 year-over-year; TTM through Nov 2025 was $1.9 million, a 0.0% change, with the full-year FY2025 number at $1.9 million, changed 0.0% from a year prior.
  • Goodwill was $1.9 million for Q4 2025 at Cryo Cell International, roughly flat from $1.9 million in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $1.9 million in Q1 2021 to a low of $1.9 million in Q1 2021.
  • A 5-year average of $1.9 million and a median of $1.9 million in 2021 define the central range for Goodwill.
  • Biggest YoY gain for Goodwill was 0.0% in 2021; the steepest drop was 0.0% in 2021.
  • Cryo Cell International's Goodwill stood at $1.9 million in 2021, then changed by 0.0% to $1.9 million in 2022, then changed by 0.0% to $1.9 million in 2023, then changed by 0.0% to $1.9 million in 2024, then changed by 0.0% to $1.9 million in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Goodwill are $1.9 million (Q4 2025), $1.9 million (Q3 2025), and $1.9 million (Q2 2025).